Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Rectal Cancer
- Sponsor
- University Hospital, Ghent
- Enrollment
- 187
- Locations
- 1
- Primary Endpoint
- Assessment QoL
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Quality of life and risk factors for developing major LARS are explored. Therapeutic options were explored in the cohort experiencing major LARS
Detailed Description
Quality of life and risk factors for developing major LARS are explored using the EORTC QLQ C30. Therapeutic options were explored in the cohort experiencing major LARS
Investigators
GIHeelkunde
Clinical nurse specialist digestive oncology
University Hospital, Ghent
Eligibility Criteria
Inclusion Criteria
- •low anterior resection for rectal cancer between 2006-2016
Exclusion Criteria
- •abdomino perineal resection
- •patients who do not understand Dutch
Outcomes
Primary Outcomes
Assessment QoL
Time Frame: up to 10 years after rectal resection
Assessments using questionnaire European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ C30)
frequencies of therapeutic options to manage LARS
Time Frame: up to 10 years after rectal resection
Self developed questionaire to determine what therapeutic options were used to manage LARS
Frequency of LARS
Time Frame: up to 10 years after rectal resection
Assessment of LARS using validated LARS Score